Esteemed Industry Speaker
Conferences, Seminars and Presentations
Allan B. Haberman, Ph.D. speaks at national and international conferences on the pharmaceutical and biotechnology industry and on drug discovery and development.
He and his associates also offer presentations and interactive seminars at your company, designed to help you meet key challenges in technology strategy, product development, R&D productivity, and business development.
Speaking Topics Include
- Biotechnology and the future of the pharmaceutical industry
- Effective drug discovery and development in the post-genomic era
- New approaches to drug discovery and development in key therapeutic areas
- Cardiovascular diseases
- Metabolic diseases
- Immune and inflammatory diseases
- Neurodegenerative diseases
Allan B. Haberman, Ph.D.
Pharmaceutical and Biotechnology Industry
Animal Models for Therapeutic Strategies, 2010
“..poorly predictive animal models are a major cause of drug attrition during development. This is especially seen in therapeutic areas in which current animal models are the most unpredictive, such as oncology and central nervous system (CNS) diseases; these are the therapeutic areas with the highest rates of Phase 2 and 3 attrition…Not only do industry researchers and leaders see the need for more predictive animal models, but also the US National Institutes of Health (NIH) and the FDA. In the FDA’s Critical Path Initiative, the agency recognizes the need for improved animal models as a critical bottleneck in drug discovery and development. Poorly predictive animal models used in target validation and preclinical studies may especially be a major cause of efficacy failures in the clinic.”